Abstract
The investigation of chromosomal aberrations in adrenocortical tumours has been limited by the difficulties of applying classical cytogenetics to tumours with low levels of proliferation. We have therefore applied the technique of interphase cytogenetics to paraffin-embedded archival specimens of 14 adrenocortical adenomas and 13 carcinomas. Hybridizations were performed using centromere-specific probes to chromosomes 3, 4, 9, 17, 18 and X, which have been shown to be altered in other types of tumours. Chromosomal imbalance was defined on the basis of changes in both chromosome index (CI) and signal distribution (SD). Where only one of these was altered, this was classified as a tendency to gain or loss. On the basis of the analysis of optimal hybridizations, carcinomas showed gains in all chromosomes studied, five of nine showing gains in multiple chromosomes. Gains were most common in chromosomes 3, 9 and, in particular X, eight of 11 showing gain, and one a tendency to gain. Chromosomal gain was seen less commonly in adenomas, but again chromosomes 3, 9 and X were involved. Losses were infrequent, only one carcinoma showing loss of chromosome 18, and adenomas showing a tendency to loss of chromosomes 4 (two cases), 17 (one case) and 18 (two cases). Our data suggest that changes in chromosomes 3, 9 and X are early events in adrenocortical tumorigenesis, and that there is increasing chromosomal instability with tumour progression.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baretton, GB, Valina, C, Vogt, T, Schneiderbanger, K, Diebold, J & Lohrs, U (1994) Interphase cytogenetic analysis of prostatic carcinomas by use of non-isotopic in situ hybridization. Cancer Res 54: 4472–4480
Bulten, J, Poddighe, PJ, Robben, JCM, Gemmink, JH, de Wilde, PCM & Hanselaar, AGJM (1998) Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol 152: 495–503
Cornelisse, CJ, Kuipers-Dijkshoorn, N, van Vliet, M, Hermans, J & Devilee, P (1992) Franctional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss. Int J Cancer 50: 544–548
Devilee, P, Schuuring, E, van der Vijer, MJ & Cornelisse, CJ (1994) Recent developments in the molecular genetic understanding of breast cancer. Crit Rev Oncol 5: 247–270
Dhingra, K, Sneige, N, Pandita, TK, Johnston, DA, Lee, JS, Emami, K, Hortobagyi, GN & Hitletman, WN (1994) Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. Cytometry 16: 100–112
Dobbie, JW (1969) Adrenocortical nodular hyperplasia. The ageing adrenal gland. J Pathol 99: 1–18
Feng, J, Funk, WD, Wang, S-S, Weinrich, SL, Avilion, AA, Chiu, C-P, Adams, RR, Chang, E, Allsopp, RC, Yu, J, Le, S, West, MD, Harley, CB, Andrews, WH, Greider, CW & Villeponteau, B (1995) The RNA component of human telomerase. Science 269: 1236–1241
Guo, W, Burris, TP, Zhang, YH, Huang, BL, Mason, J, Copeland, KC, Kupfer, SR, Pagon, RA & McCabe, ER (1996) Genomic sequence of the DAX 1 gene: an orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. J Clin Endocrinol Metab 81: 2481–2486
Hahn, SA, Schutte, M, Hoque, TMS, Moskaluk, CA, da Costa, LT, Rozenblum, E, Weinstein, CL, Fischer, A, Yeo, CJ, Hruban, RH & Kern, SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350–354
Henry, I, Grandjouan, S, Couillin, P, Barichard, F, Huerre-Jeanpierre, C, Glaser, T, Philip, T, Lenoir, G, Chaussain, J & Junien, C (1989) Tumor-specific loss of 11p15.5 alleles in del 11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 86: 3247–3251
Hirano, Y, Fujita, K, Suzuki, K, Ushiyama, T, Ohtawara, Y & Tsuda, F (1998) Telomerase activity as an indicator of potentially malignant adrenal tumors. Cancer 83: 772–776
Hopman, AH, Poddighe, P, Moesker, O & Ramaekers, FC (1992). In: Diagnostic molecular pathology: a practical approach 1, Herrington CS, McGee J O’D (ed) IRL IRL Press: Arlington (VA) 141–167
Iida, A, Blake, K, Tunny, T, Klemm, S, Stowasser, M, Hayward, N, Gordon, R, Nakamura, Y & Imai, T (1995) Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors. Genes Chromosomes Cancer 12: 73–75
Ilvesmaki, V, Kahri, AI, Miettinen, PJ & Voutilainen, R (1993) Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab 77: 852–858
Kamb, A, Gruis, NA, Weaver-Feldhaus, J, Liu, Q, Harshman, K, Tavtigian, SV, Stockert, E, Day, RS, Johnson, BE & Skolnick, MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440
Kananen, K, Markkula, M, Mikola, M, Rainio, EM, McNeilly, A & Huhtaniemi, I (1996) Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/Simian virus-40-T-antigen fusion gene – evidence for negative autoregulation of the inhibin alpha subunit gene. Mol Endocrinol 10: 1667–1677
Karakousis, CP, Rao, V & Moore, R (1985) Adrenal adenocarcinomas – histologic grading and survival. J Surg Oncol 29: 105–111
Kingsley, DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in individual organisms. Genes Dev 8: 133–146
Kjellman, M, Kallioniemi, O-P, Karhu, R, Höög, A, Farnebo, L-O, Auer, G, Larsson, C & Bäckdahl, M (1996) Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res 56: 4219–4223
Lack, EE, Travis, WD & Oertel, JE (1990). Adrenal cortical nodules, hyperplasia and hyperfunction. In: Pathology of the Adrenal Gland, Lack EE (ed), pp. 75–113. Churchill Livingstone: New York
Li, FP & Fraumeni, JF Jr (1969) Soft-tissue sarcomas, breast cancer and other neoplasms: a familial syndrome? Ann Intern Med 71: 747–752
Macoska, JA, Micale, MA, Sakr, WA, Benson, PD & Wolman, SR (1993) Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer 8: 88–97
McBride, OW, Merry, D & Givol, D (1986) The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 83: 130–134
McNicol, AM (1992) The human adrenal gland. Aspects of structure, function and pathology. In:The Adrenal Gland, 2nd edn.James VHT (ed) Raven Press Ltd: New York pp. 1–42
McNicol, AM, Nolan, CE, Struthers, AJ, Farquharson, MA, Hermans, J & Haak, HR (1997) Expression of p53 in adrenocortical tumours: clinicopathological correlations. J Pathol 181: 146–152
Matzuk, MM, Finegold, MJ, Mather, JP, Krummen, L & Bradley, A (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin deficient mice. Proc Natl Acad Sci USA 91: 8817–8821
Murphy, DS, Hoare, SF, Going, JJ, Mallon, EA, George, WD, Kaye, SB, Brown, R, Black, DM & Keith, WN (1995) Characterization of extensive genetic alterations in ductal carcinoma by in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 87: 1694–1704
Ohgaki, H, Kleihues, P & Heitz, PU (1993) P53 mutations in sporadic adrenocortical tumors. Int J Cancer 54: 408–410
Poddighe, PJ, Ramaekers, FC & Hopman, AH (1992) Interphase cytogenetics of tumors. J Pathol 166: 215–224
Prinz, RA, Brooks, MH, Churchill, R, Graner, JL, Lawrence, AM, Paloyan, E & Sparagana, M (1982) Incidental adrenal masses detected by computed tomographic scanning – is operation required? JAMA 248: 701–704
Ried, T (1998) Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am J Pathol 152: 325–327
Rosenberg, C, Dellarosa, VA, Latronico, AC, Mendonca, BE & Vianna Morgante, AM (1995) Selection of adrenal tumor cells in culture demonstrated by interphase cytogenetics. Cancer Genet Cytogenet 79: 36–40
Sasano, N, Takezawa, Y, Sato, H & Horikawa, N (1971) Microangiography of normal and pathological human adrenals in prenatal and aging course. Tohoku J Exp Med 104: 129–141
Shackney, SE, Smith, CA, Miller, BW, Burholt, DR, Murtha, K, Giles, HR, Ketterer, DM & Pollice, AA (1989) Model for the genetic evolution of human solid tumors. Cancer Res 49: 3344–3354
Skogseid, B, Larsson, C, Lindgren, P, Kvanta, E, Rastad, J, Theodorsson, E, Wide, L, Wilander, E & Öberg, K (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75: 76–81
Sneige, N, Sahin, A, Dinh, M & El-Naggar, A (1996) Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol 27: 330–335
Srivastava, S, Zou, Z, Pirollo, K, Blattner, W & Chang, EH (1990) Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348: 747–749
Thompson, NW & Cheung, PSY (1987) Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas. Surg Clin North Am 67: 423–436
Van Slooten, H, Schaberg, A, Smeenk, D & Moolenaar, AJ (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55: 766–773
Visscher, DW, Wallis, TL & Crissman, JD (1996) Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 77: 315–320
Vogelstein, B, Fearon, ER, Hamilton, SR, Kern, SE, Preisinger, AC, Leppert, M, Nakamura, Y, White, R, Smits, AMM & Bos, JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319: 525–532
Weksberg, R, Teshima, I, Williams, BRG, Greenberg, CR, Pueschel, SM, Chernos, JE, Fowlow, SB, Hoyme, E, Anderson, IJ, Whiteman, DAH, Fisher, N & Squire, J (1993) Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) refines the localization and suggests the gene for BWS is imprinted. Hum Mol Genet 2: 549–556
Yano, T, Linehan, M, Anglard, P, Lerman, M, Daniel, L, Stein, C, Robertson, C, LaRocca, R & Zbar, B (1989) Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst 81: 518–523
Author information
Authors and Affiliations
Additional information
Correspondence to:AM McNicol
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Russell, A., Sibbald, J., Haak, H. et al. Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage. Br J Cancer 81, 684–689 (1999). https://doi.org/10.1038/sj.bjc.6690748
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690748
Keywords
This article is cited by
-
Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC)
Virchows Archiv (2018)
-
Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases
Virchows Archiv (2017)
-
Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed
Oncogene (2010)
-
A Diagnostic Approach to Adrenal Cortical Lesions
Endocrine Pathology (2008)
-
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas
Virchows Archiv (2006)